Cambridge Healthtech Institute's Biomarker Series signature event, the 12th Annual Biomarkers & Diagnostics World Congress, was recently held May 17 – 19, in Philadelphia, PA.

This year’s event featured more than 400 participants, from 20 different countries and more than 218 different organizations (including 25% from Pharma). The congress offered a balance of scientific sessions and ample networking opportunities. More than 60% of the participants were decision makers. The latest research and strategic presentations and brainstorming sessions were featured at this year’s event. The Biomarker World Congress once again delivered, with more than 100 presentations, and a sold-out exhibit hall.

Key Contacts